PINTO, FRANCESCO
PINTO, FRANCESCO
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
[Asn31(N-beta-D-Glucopyranosyl)]hMOG(30-50): an antigen to identify anti-hMOG peptide antibodies in multiple sclerosis patients.
1998 A.M. PAPINI; S. MAZZUCCO; R. FIORESI; E. NARDI; M. GINANNESCHI; M. CHELLI; S. MATÀ; F. LOLLI; F. PINTO; B. MAZZANTI; L. MASSACESI; M. VERGELLI
A simple pressure microinjecting system for delivery of small substances volumes to the brain. Application to the developmental study of thalamo-cortical projections in foetal and neonatal rats.
1999 SBRICCOLI A; CARRETTA D; SANTARELLI M; PINTO F; GRANATO A; D. MINCIACCHI
A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases
1999 Mazzucco, S; Matà, S; Vergelli, M; Fioresi, R; Nardi, E; Mazzanti, B; Chelli, M; Lolli, F; Ginanneschi, M; Pinto, F; Massacesi, L; Papini, A M
Absent SEP during therapeutic hypothermia did not reappear after re-warming in comatose patients following cardiac arrest.
2013 Grippo A;Carrai R;Fossi S;Cossu C;Mazzeschi E;Peris A;Bonizzoli M;Ciapetti M;Gensini GF;Pinto F;Amantini A
Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barre syndrome.
2006 S. MATÀ; E. GALLI; F. PINTO; S. SORBI; F. LOLLI; A. AMANTINI
Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barré syndrome (GBS).
1998 S. Matà; G. Avanzi; R. Lombardo; F. Cepparone; F. Pinto; F. Lolli
Anti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy.
2006 S. Matà; D. Renzi; F. Pinto; A. Calabrò
Architectural changes of the cortico-spinal system in the dystrophin defective mdx mouse.
1995 SBRICCOLI A; SANTARELLI M; CARRETTA D; PINTO F; GRANATO A; D. MINCIACCHI
Continuous EEG-SEP monitoring in severe braininjury
2009 A. Amantinia; S. Fossi; A. Grippo; P. Innocenti; A. Amadori; L. Bucciardini; C. Cossu; C. Nardini; S. Scarpelli; V. Roma; F. Pinto
Continuous EEG-SEP monitoring of severely brain injured patients in NICU: methods and feasibility
2006 FOSSI.S,Amantini.a, GRIPPO.A; INNOCENTI.P; AMADORI.A; BUCCIARDINI.L; COSSU.C; SCARPELLI.S; BRUNI.I; SGALLA.R; F.PINTO
Cortical and brainstem neurons containing calcium-binding proteins in a murine model of Duchenne muscular dystrophy: selective changes in the sensorimotor cortex.
2003 D. Carretta; M. Santarelli; D. Vanni; S. Ciabatti; A. Sbriccoli; F. Pinto; D. Minciacchi
Crossed thalamo-cortical and cortico-thalamic projections in adult mice.
1996 CARRETTA D; SBRICCOLI A; SANTARELLI M; PINTO F; GRANATO A; D. MINCIACCHI
Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP.
1997 S. Sivieri; A. M. Ferrarini; F. Lolli; S. Matà; F. Pinto; B. Tavolato; P. Gallo
Electrophysiological study of neurologically asymptomatic HIV1 seropositive patients.
1993 RAGAZZONI A; GRIPPO A; GHIDINI P; SCHIAVONE V; F. LOLLI; MAZZOTTA F; MECOCCI L; PINTO F.
Glycopeptides of hMOG(30-50) Detect Antibody Response in Multiple Sclerosis and other Neurological Diseases.
1999 S. MAZZUCCO; R. FIORESI; S. MATÀ; M. VERGELLI; M. CHELLI; F. LOLLI; M. GINANNESCHI; F. PINTO; B. MAZZANTI; L. MASSACESI; G. RAPI; A. PAPINI
Immuno-absorption columns for the subtraction of antibodies from blood with selective plasma filtration techniques
2003 F. PINTO; A. PAPINI; M. CHELLI; P. ROVERO; F. LOLLI
Intrathecal synthesis of anti-HIV antibodies in AIDS patients.
1990 F. LOLLI; COLAO MG; DE MAIO E; DI PIETRO M; GALLI E; GRIPPO A; MAZZOTTA F; PINTO F.
Motor nerve damage is associated with anti-ganglioside antibodies in diabetes
2004 Mata S.; Betti E.; Masotti G.; Pinto F.; Lolli F.
Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a.
1999 MATA S; F. LOLLI; SODERSTROM M; F. PINTO; LINK H.
Neurological damage in patients irradiated twice on the spinal cord: a morphologic and electrophysiologic study
1990 MAGRINI SM; G. BITI; DE SCISCIOLO G; BARTELLI M; PINTO F